Randomized phase II trial comparing carboplatin plus weekly paclitaxel and docetaxel alone in elderly patients with advanced non-small cell lung cancer: North Japan lung cancer group trial 0801

Oncologist

Volumn 19, Issue 4, 2014, Pages 352-353

  Maemondo, Makoto ^a   Inoue, Akira ^b   Sugawara, Shunichi ^c   Harada, Toshiyuki ^d   Minegishi, Yuji ^e   Usui, Kazuhiro ^f   Miwa, Koji ^g   Morikawa, Naoto ^h   Kambe, Mariko ⁱ   Ube, Kenji ^j   Watanabe, Kana ^a   Ishimoto, Osamu ^c   Sakakibara, Tomohiro ^b   Gemma, Akihiko ^e   Nukiwa, Toshihiro ^k  

^a Miyagi Cancer Center   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c SENDAI KOUSEI HOSPITAL   (Japan)

^d Hokkaido Social Insurance Hospital   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

^f Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

^g Tsuboi Cancer Center Hospital   (Japan)

^h IWATE MEDICAL UNIVERSITY   (Japan)

ⁱ Senseki Hospital   (Japan)

^j Iwate Prefectural Central Hospital   (Japan)

^k South Miyagi Medical Center   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DOCETAXEL; PACLITAXEL; ANTINEOPLASTIC AGENT; TAXOID;

ARTICLE; FEBRILE NEUTROPENIA; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; NAUSEA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; AGED; AGING; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; JAPAN; LUNG NEOPLASMS; MORTALITY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; HUMANS; JAPAN; LUNG NEOPLASMS; PACLITAXEL; TAXOIDS; TREATMENT OUTCOME;

EID: 84898444917     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0411     Document Type: Article

References (0)